搜索临床试验以:核心治疗活性实验:SHR0302 剂量 #2
总计1315个结果
-
University of Michigan Rogel Cancer Center完全的
-
Massachusetts General HospitalGlaxoSmithKline招聘中
-
Bond Avillion 2 Development LP完全的哮喘美国, 德国, 乌克兰, 塞尔维亚, 捷克语, 阿根廷, 斯洛伐克
-
The Lymphoma Academic Research OrganisationFrench Innovative Leukemia Organisation完全的
-
Hospices Civils de Lyon未知
-
Augusta UniversityYale University; University of Alabama at Birmingham; Tufts University未知
-
University Hospital, Antwerp招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止
-
Perrault Louis P.Montreal Heart Institute; Somahlution LLC完全的
-
Janssen Research & Development, LLC完全的
-
Raymond T. Chung, MDMerck Sharp & Dohme LLC撤销
-
University of MichiganUniversity of Colorado, Denver; Renal Pre-Competitive Consortium (RPC3)招聘中
-
The First Affiliated Hospital of Soochow UniversityPeking University People's Hospital; Qilu Hospital of Shandong University; Nanfang Hospital of... 和其他合作者完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
ANRS, Emerging Infectious DiseasesRoche Pharma AG未知
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)邀请报名
-
Assistance Publique - Hôpitaux de Paris尚未招聘急性呼吸衰竭 | 免疫功能低下的患者
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Institut PasteurAssistance Publique Hopitaux De Marseille; Ministry of Health, France; Hôpital Necker-Enfants... 和其他合作者尚未招聘
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)招聘中
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Douglas Pharmaceuticals America LtdNovum Pharmaceutical Research Services; ACM Global Laboratories完全的
-
University of Michigan Rogel Cancer CenterRush University Medical Center完全的